References
- Battu SK, Repka MA, Majumdar S, Madhusudan RY. Formulation and evaluation of rapidly disintegrating fenoverine tablets: effect of superdisintegrants. Drug Dev Ind Pharm 2007,33:1225–1232.
- Oshima T, Sonoda R, Ohkuma M, Sunada H. Preparation of rapidly disintegrating tablets containing itraconazole solid dispersions. Chem Pharm Bull 2007,55:1557–1562.
- Gonnissen Y, Gonçalves SI, De Geest BG, Remon JP, Vervaet C. Process design applied to optimize a directly compressible powder produced via a continuous manufacturing process. Eur J Pharm Biopharm 2008,68:760–770.
- Souto C, Rodriguez A, Parajes S, Martınez-Pacheco R. A comparative study of the utility of two superdisintegrants in microcrystalline cellulose pellets prepared by extrusion-spheronization. Eur J Pharm Biopharm, 2005,61:94–99.
- Mizumoto T, Masuda Y, Yamamoto T, Yonemochi E, Terada K. Formulation design of a novel fast-disintegrating tablet. Int J Pharm 2005,306:83–90.
- Amidon GL, Lennernäs H, Shah VP, Crison JR. A theoretical basic for a biopharmaceutic drug classification: The correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res 1995,12:413–420.
- Lindenberg M, Kopp S, Dressman JB. Classification of orally administered drugs on the World Health Organization Model list of Essential Medicines according to the biopharmaceutics classification system. Eur J Pharm Biopharm 2004;58:265–278.
- Pedersen PV, Gobburu JVS, Meyers MC, Straughn AB. Carbamazepine level-A in vitro-in vivo correlation (IVIVC): A scaled convolution based predictive approach. Biopharm Drug Dispos 2000,21:1–6.
- Uppoor VRS. Regulatory perspectives on in vitro (dissolution)/in vivo (bioavailability) correlations. J Control Release 2001,72:127–132.
- UNIFESP, Oswaldo Ramos Foundation, Kidney and Hypertension Hospital. Bioequivalence study of two ketocanazole 200 mg tablet formulations. São Paulo, Brazil:UNIFESP; 2000.
- Pascucci VL, Bennet J, Narang PK, Chatterji DC. Quantitation of Ketoconazole in biological fluids using high performance liquid chromatography. J Pharm Sci 1983,12:1467–1469.
- Yuen KH, Peh KK. Simple high performance liquid chromatographic method for determination of ketoconazole in human plasma. J Chromatogr B Biomed Sci 1998,715:436–440.
- Mosharraf M, Nyström C. The effect of particle size shape on the surface specific dissolution rate of microsized practically insoluble drugs. Int J Pharm 1995,122:35–47.
- Mosharraf M, Nyström C. The effect of dry mixing on the apparent solubility of hydrophobic, sparingly soluble drugs. Eur J Pharm Sci 1999,9:145–156.
- Viseras C, Salem II, Galan ICR, Galan A, Galindo AL. The effect of recrystallization on the crystal growth, melting point and solubility of ketoconazole. Thermochimica acta 1995,268:143–151.
- Yang Z, Wong CS, Yang C, Jiang ZH, Zhao Z, Liu L. Control release effects of binders used in pills of traditional Chinese medicine herbs. Chem Pharm Bull 2006,54:188–195.
- Spiegeleer BD, Vooren LV, Voorspoels J, Thoné; D, Rosier J. Dissolution stability and IVIVC investigation of bucal tablet. Anal Chim Acta 2001,446:345–351.
- Shah U, Ausburger L. Multiple sources of sodium starch glycolate: Evaluation of functional equivalence and development of standard performance tests. Pharm Dev Technol 2002,7:345–359.
- Hwang RR, Kowalski DL. Design of experiments for formulation development. PharmTech.com; 1 December 2005.
- Zhao N, Augsburger LL. The influence of product brand-to-brand variability on superdisintegrant performance. A case study with croscarmellose sodium. Pharm Dev Technol 2006,11:179–185.
- Joshi A, Duriez X. Added functionality excipients: An answer to challenging formulations. Pharm Technol 2004;34:12–19.